Delivery Order SPE2DB20D3303-SPE2DB23FZ9V6

Award Date 7/19/23
Potential Completion Date 8/9/23
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $6,166.42 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 40 tablets of Lonsurf 20 mg-8.19 mg for cancer treatment. To be performed at the prime contractor's facility in Conshohocken, Pennsylvania, the order is for the delivery of the specified pharmaceutical product between September 13 and October 4, 2023. Amerisourcebergen will fulfill the delivery order as the prime contractor, with the Defense Logistics Agency...
The Defense Logistics Agency awarded a $6,166.42 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 tablets of 20 mg-8.19 mg Lonsurf to treat cancer. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by August 15, 2023 to support the Defense Logistics Agency's mission. No subcontractors or set aside designations were identified. The delivery order was awarded against...
The Defense Logistics Agency awarded a $9,086.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 40 tablets of Lonsurf 15 mg-6.14 mg for cancer treatment. The contract has a period of performance from September 1, 2023 through September 25, 2023, with performance taking place in Conshohocken, Pennsylvania. As the DLA supports the procurement of pharmaceuticals and medical supplies for the Department of Defense, this delivery order likely provides cancer...
The Defense Logistics Agency awarded a $6,166.42 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 40 tablets of 20mg-8.19mg Lonsurf to treat cancer. Amerisourcebergen Drug Corporation will deliver the medication to a location in Conshohocken, Pennsylvania by August 28, 2023 to support the Defense Logistics Agency's mission. As the prime contractor, Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation and will perform the order...
The Defense Logistics Agency awarded a $9,086.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 tablets of Lonsurf 15 mg-6.14 mg to treat cancer. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the chemotherapy medication from its facility in Conshohocken, Pennsylvania to the Defense Logistics Agency by September 5, 2023 to support the agency's mission. No subcontractors or set aside designations were identified in the award information. The...
This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corporation $9,158.32 to supply 60 Lonsurf 20 mg-8.19 mg tablets by November 15, 2023. The firm fixed price contract has a place of performance in Conshohocken, Pennsylvania and does not include any set-aside designations. As a major provider of pharmaceuticals, medical supplies, and logistics support to the U.S. military and other government agencies, this order allows the Defense Logistics Agency to fulfill...
The Defense Logistics Agency awarded a $9,158.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 Lonsurf 20 mg-8.19 mg tablets. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one month period concluding in mid-October 2023. No set aside designation or subcontracting...
The Defense Logistics Agency awarded a $9,086.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561503738 LONSURF 15 MG-6.14 MG tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 40 tablets of LONSURF to its place of performance in Conshohocken, Pennsylvania by August 4, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in both...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,173.33 firm fixed-price delivery order is for the supply of the medication LONSURF 20 MG-8.19 MG TABLET 60S, with a performance period ending on March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $9,599.25, and has an ultimate completion date of August 5, 2024. The contract is for the pharmaceutical product LONSURF 20 MG-8.19 MG TABLET 60S, which falls under the DLA Troop Support Medical program. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB23FZ9V6
    Delivery Order

The Defense Logistics Agency awarded a $12,332.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 tablets of 20 mg-8.19 mg Lonsurf to treat cancer. As the prime contractor, Amerisourcebergen will deliver the chemotherapy medication to a facility in Conshohocken, Pennsylvania within the July 19 to August 9, 2023 period of performance. No subcontractors or set aside designations were specified. This order is likely in support of the Defense Health Agency's mission to provide health care services and support to military members, veterans, and their families.

Generated 12/16/23, 5:39 AM